CN Stock MarketDetailed Quotes

600976 Jianmin Pharmaceutical Group

Watchlist
  • 47.09
  • +0.29+0.62%
Market Closed Jul 17 15:00 CST
7.22BMarket Cap13.85P/E (TTM)

Jianmin Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-4.27%970.12M
15.72%4.21B
10.95%3.12B
17.67%2.16B
10.40%1.01B
10.35%3.64B
7.83%2.81B
2.46%1.84B
9.10%917.94M
34.34%3.3B
Operating revenue
-4.27%970.12M
15.72%4.21B
10.95%3.12B
17.67%2.16B
10.40%1.01B
10.35%3.64B
7.83%2.81B
2.46%1.84B
9.10%917.94M
34.34%3.3B
Other operating revenue
----
35.51%23.59M
----
9.23%7.68M
----
123.13%17.41M
----
117.38%7.03M
----
-31.11%7.8M
Total operating cost
-2.70%932.86M
15.60%3.89B
9.71%2.88B
14.91%2B
10.09%958.75M
8.87%3.37B
7.67%2.62B
3.72%1.74B
9.14%870.9M
28.81%3.09B
Operating cost
9.34%557.83M
10.06%2.27B
2.27%1.65B
5.18%1.16B
-2.51%510.17M
9.83%2.07B
7.09%1.61B
5.43%1.1B
16.74%523.3M
28.98%1.88B
Operating tax surcharges
-29.90%5.35M
18.00%29.03M
23.85%22.16M
44.93%15.78M
32.51%7.63M
6.86%24.6M
0.47%17.89M
-15.58%10.89M
-7.08%5.76M
53.79%23.02M
Operating expense
-19.76%304.27M
25.77%1.34B
22.43%1.02B
32.90%700.49M
29.86%379.2M
7.77%1.07B
4.59%832.93M
-2.46%527.08M
-4.34%292M
25.98%991.88M
Administration expense
-4.74%42.1M
26.76%172.37M
21.74%136.18M
33.19%87.49M
31.82%44.2M
-2.01%135.98M
23.08%111.86M
8.35%65.69M
13.05%33.53M
33.05%138.76M
Financial expense
232.31%366.1K
70.58%1.09M
-92.19%181.47K
-107.01%-190.62K
68.20%-276.71K
-91.40%637.62K
43.44%2.32M
138.72%2.72M
-372.16%-870.21K
3,060.13%7.42M
-Interest expense (Financial expense)
2,734.42%1.31M
-23.09%3.7M
-61.93%2.27M
-82.03%897.34K
-94.26%46.2K
-44.76%4.81M
151.88%5.95M
289.79%4.99M
155.98%804.3K
1,489.77%8.71M
-Interest Income (Financial expense)
-149.17%-1.19M
24.78%-3.73M
31.76%-2.84M
44.73%-1.62M
73.41%-476.3K
-177.11%-4.96M
-294.47%-4.17M
-479.92%-2.92M
-1,782.17%-1.79M
-147.61%-1.79M
Research and development
28.77%22.95M
1.17%74.05M
9.90%52.01M
16.49%35.14M
3.73%17.82M
39.12%73.19M
84.71%47.33M
88.43%30.17M
108.43%17.18M
40.67%52.61M
Credit Impairment Loss
----
63.53%-10.08M
----
----
----
-342.45%-27.62M
-99.06%2.51K
-111.29%-30.3K
-99.38%1.67K
-354.42%-6.24M
Asset Impairment Loss
----
-52.95%-14.89M
--383.87K
--383.87K
--383.87K
-164,806.88%-9.74M
----
----
----
99.62%-5.9K
Other net revenue
28.80%72.35M
49.83%254.75M
36.42%217.88M
6.63%118.86M
10.17%56.17M
20.62%170.03M
39.46%159.71M
59.40%111.48M
46.55%50.98M
31.80%140.97M
Fair value change income
-10.57%7.52M
151.01%6.18M
43.77%21.69M
60.26%14.57M
75.90%8.41M
-391.83%-12.11M
70.75%15.09M
75.07%9.09M
109.49%4.78M
-53.51%-2.46M
Invest income
35.85%59.77M
42.52%231.31M
46.09%169.82M
18.89%93.04M
8.36%44M
29.15%162.3M
18.55%116.24M
25.29%78.25M
31.92%40.61M
20.62%125.67M
-Including: Investment income associates
35.53%60.62M
23.16%185.21M
28.11%147.73M
24.58%96.33M
11.79%44.73M
33.71%150.38M
22.41%115.32M
29.56%77.33M
34.66%40.01M
18.42%112.47M
Asset deal income
-50.33%17.51K
2,946.75%683.31K
106.63%35.26K
110.97%35.26K
110.97%35.26K
-104.98%-24K
-254.08%-531.84K
-95.16%16.71K
-95.16%16.71K
658.10%481.77K
Other revenue
50.79%5.04M
-27.39%41.55M
-10.22%25.96M
-55.12%10.84M
-40.09%3.34M
143.23%57.23M
311.76%28.91M
1,345.14%24.14M
401.14%5.58M
218.73%23.53M
Operating profit
-1.09%109.61M
29.78%573.86M
31.99%459.39M
34.57%283.33M
13.04%110.81M
27.70%442.17M
21.89%348.05M
12.52%210.55M
25.31%98.03M
115.32%346.26M
Add:Non operating Income
-77.96%65.75K
150.05%849.48K
239.43%1.09M
629.88%918.13K
571.98%298.34K
27.31%339.73K
44.16%321.55K
-30.67%125.79K
48.96%44.4K
39.23%266.85K
Less:Non operating expense
92.95%1.43M
-20.87%3.62M
-34.13%1.33M
-2.77%1.11M
340.77%742.75K
-9.90%4.57M
-25.32%2.02M
46.84%1.15M
6.01%168.51K
49.43%5.07M
Total profit
-1.93%108.24M
30.40%571.09M
32.57%459.15M
35.13%283.14M
12.73%110.37M
28.26%437.94M
22.36%346.35M
12.34%209.53M
25.36%97.9M
116.65%341.45M
Less:Income tax cost
-23.80%8.04M
49.90%47.86M
37.11%42.46M
40.98%29.9M
15.35%10.55M
-10.09%31.93M
22.80%30.97M
11.24%21.21M
23.20%9.15M
298.04%35.51M
Net profit
0.38%100.2M
28.87%523.23M
32.12%416.69M
34.47%253.23M
12.46%99.81M
32.71%406.01M
22.31%315.38M
12.46%188.32M
25.58%88.76M
105.76%305.94M
Net profit from continuing operation
0.38%100.2M
25.61%529.91M
32.12%416.69M
34.47%253.23M
12.46%99.81M
37.89%421.88M
22.31%315.38M
12.46%188.32M
25.58%88.76M
105.76%305.94M
Net income from discontinuing operating
----
57.92%-6.68M
----
----
----
---15.86M
----
----
----
----
Less:Minority Profit
165.66%673.49K
185.98%1.78M
193.48%1.57M
392.03%861K
431.06%253.51K
-401.80%-2.07M
-28.20%533.75K
-41.74%174.99K
-80.33%47.74K
-23.78%684.53K
Net profit of parent company owners
-0.04%99.52M
27.78%521.46M
31.85%415.12M
34.14%252.37M
12.23%99.56M
33.68%408.08M
22.46%314.85M
12.56%188.15M
25.95%88.71M
106.55%305.26M
Earning per share
Basic earning per share
0.00%0.65
27.24%3.41
31.40%2.72
33.06%1.65
12.07%0.65
33.33%2.68
22.49%2.07
12.73%1.24
26.09%0.58
109.38%2.01
Diluted earning per share
0.00%0.65
27.24%3.41
31.40%2.72
33.06%1.65
12.07%0.65
33.33%2.68
22.49%2.07
12.73%1.24
26.09%0.58
109.38%2.01
Other composite income
Total composite income
0.38%100.2M
28.87%523.23M
32.12%416.69M
34.47%253.23M
12.46%99.81M
32.71%406.01M
22.31%315.38M
12.46%188.32M
25.58%88.76M
105.76%305.94M
Total composite income of parent company owners
-0.04%99.52M
27.78%521.46M
31.85%415.12M
34.14%252.37M
12.23%99.56M
33.68%408.08M
22.46%314.85M
12.56%188.15M
25.95%88.71M
106.55%305.26M
Total composite income of minority owners
165.66%673.49K
185.98%1.78M
193.48%1.57M
392.03%861K
431.06%253.51K
-401.80%-2.07M
-28.20%533.75K
-41.74%174.99K
-80.33%47.74K
-23.78%684.53K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -4.27%970.12M15.72%4.21B10.95%3.12B17.67%2.16B10.40%1.01B10.35%3.64B7.83%2.81B2.46%1.84B9.10%917.94M34.34%3.3B
Operating revenue -4.27%970.12M15.72%4.21B10.95%3.12B17.67%2.16B10.40%1.01B10.35%3.64B7.83%2.81B2.46%1.84B9.10%917.94M34.34%3.3B
Other operating revenue ----35.51%23.59M----9.23%7.68M----123.13%17.41M----117.38%7.03M-----31.11%7.8M
Total operating cost -2.70%932.86M15.60%3.89B9.71%2.88B14.91%2B10.09%958.75M8.87%3.37B7.67%2.62B3.72%1.74B9.14%870.9M28.81%3.09B
Operating cost 9.34%557.83M10.06%2.27B2.27%1.65B5.18%1.16B-2.51%510.17M9.83%2.07B7.09%1.61B5.43%1.1B16.74%523.3M28.98%1.88B
Operating tax surcharges -29.90%5.35M18.00%29.03M23.85%22.16M44.93%15.78M32.51%7.63M6.86%24.6M0.47%17.89M-15.58%10.89M-7.08%5.76M53.79%23.02M
Operating expense -19.76%304.27M25.77%1.34B22.43%1.02B32.90%700.49M29.86%379.2M7.77%1.07B4.59%832.93M-2.46%527.08M-4.34%292M25.98%991.88M
Administration expense -4.74%42.1M26.76%172.37M21.74%136.18M33.19%87.49M31.82%44.2M-2.01%135.98M23.08%111.86M8.35%65.69M13.05%33.53M33.05%138.76M
Financial expense 232.31%366.1K70.58%1.09M-92.19%181.47K-107.01%-190.62K68.20%-276.71K-91.40%637.62K43.44%2.32M138.72%2.72M-372.16%-870.21K3,060.13%7.42M
-Interest expense (Financial expense) 2,734.42%1.31M-23.09%3.7M-61.93%2.27M-82.03%897.34K-94.26%46.2K-44.76%4.81M151.88%5.95M289.79%4.99M155.98%804.3K1,489.77%8.71M
-Interest Income (Financial expense) -149.17%-1.19M24.78%-3.73M31.76%-2.84M44.73%-1.62M73.41%-476.3K-177.11%-4.96M-294.47%-4.17M-479.92%-2.92M-1,782.17%-1.79M-147.61%-1.79M
Research and development 28.77%22.95M1.17%74.05M9.90%52.01M16.49%35.14M3.73%17.82M39.12%73.19M84.71%47.33M88.43%30.17M108.43%17.18M40.67%52.61M
Credit Impairment Loss ----63.53%-10.08M-------------342.45%-27.62M-99.06%2.51K-111.29%-30.3K-99.38%1.67K-354.42%-6.24M
Asset Impairment Loss -----52.95%-14.89M--383.87K--383.87K--383.87K-164,806.88%-9.74M------------99.62%-5.9K
Other net revenue 28.80%72.35M49.83%254.75M36.42%217.88M6.63%118.86M10.17%56.17M20.62%170.03M39.46%159.71M59.40%111.48M46.55%50.98M31.80%140.97M
Fair value change income -10.57%7.52M151.01%6.18M43.77%21.69M60.26%14.57M75.90%8.41M-391.83%-12.11M70.75%15.09M75.07%9.09M109.49%4.78M-53.51%-2.46M
Invest income 35.85%59.77M42.52%231.31M46.09%169.82M18.89%93.04M8.36%44M29.15%162.3M18.55%116.24M25.29%78.25M31.92%40.61M20.62%125.67M
-Including: Investment income associates 35.53%60.62M23.16%185.21M28.11%147.73M24.58%96.33M11.79%44.73M33.71%150.38M22.41%115.32M29.56%77.33M34.66%40.01M18.42%112.47M
Asset deal income -50.33%17.51K2,946.75%683.31K106.63%35.26K110.97%35.26K110.97%35.26K-104.98%-24K-254.08%-531.84K-95.16%16.71K-95.16%16.71K658.10%481.77K
Other revenue 50.79%5.04M-27.39%41.55M-10.22%25.96M-55.12%10.84M-40.09%3.34M143.23%57.23M311.76%28.91M1,345.14%24.14M401.14%5.58M218.73%23.53M
Operating profit -1.09%109.61M29.78%573.86M31.99%459.39M34.57%283.33M13.04%110.81M27.70%442.17M21.89%348.05M12.52%210.55M25.31%98.03M115.32%346.26M
Add:Non operating Income -77.96%65.75K150.05%849.48K239.43%1.09M629.88%918.13K571.98%298.34K27.31%339.73K44.16%321.55K-30.67%125.79K48.96%44.4K39.23%266.85K
Less:Non operating expense 92.95%1.43M-20.87%3.62M-34.13%1.33M-2.77%1.11M340.77%742.75K-9.90%4.57M-25.32%2.02M46.84%1.15M6.01%168.51K49.43%5.07M
Total profit -1.93%108.24M30.40%571.09M32.57%459.15M35.13%283.14M12.73%110.37M28.26%437.94M22.36%346.35M12.34%209.53M25.36%97.9M116.65%341.45M
Less:Income tax cost -23.80%8.04M49.90%47.86M37.11%42.46M40.98%29.9M15.35%10.55M-10.09%31.93M22.80%30.97M11.24%21.21M23.20%9.15M298.04%35.51M
Net profit 0.38%100.2M28.87%523.23M32.12%416.69M34.47%253.23M12.46%99.81M32.71%406.01M22.31%315.38M12.46%188.32M25.58%88.76M105.76%305.94M
Net profit from continuing operation 0.38%100.2M25.61%529.91M32.12%416.69M34.47%253.23M12.46%99.81M37.89%421.88M22.31%315.38M12.46%188.32M25.58%88.76M105.76%305.94M
Net income from discontinuing operating ----57.92%-6.68M---------------15.86M----------------
Less:Minority Profit 165.66%673.49K185.98%1.78M193.48%1.57M392.03%861K431.06%253.51K-401.80%-2.07M-28.20%533.75K-41.74%174.99K-80.33%47.74K-23.78%684.53K
Net profit of parent company owners -0.04%99.52M27.78%521.46M31.85%415.12M34.14%252.37M12.23%99.56M33.68%408.08M22.46%314.85M12.56%188.15M25.95%88.71M106.55%305.26M
Earning per share
Basic earning per share 0.00%0.6527.24%3.4131.40%2.7233.06%1.6512.07%0.6533.33%2.6822.49%2.0712.73%1.2426.09%0.58109.38%2.01
Diluted earning per share 0.00%0.6527.24%3.4131.40%2.7233.06%1.6512.07%0.6533.33%2.6822.49%2.0712.73%1.2426.09%0.58109.38%2.01
Other composite income
Total composite income 0.38%100.2M28.87%523.23M32.12%416.69M34.47%253.23M12.46%99.81M32.71%406.01M22.31%315.38M12.46%188.32M25.58%88.76M105.76%305.94M
Total composite income of parent company owners -0.04%99.52M27.78%521.46M31.85%415.12M34.14%252.37M12.23%99.56M33.68%408.08M22.46%314.85M12.56%188.15M25.95%88.71M106.55%305.26M
Total composite income of minority owners 165.66%673.49K185.98%1.78M193.48%1.57M392.03%861K431.06%253.51K-401.80%-2.07M-28.20%533.75K-41.74%174.99K-80.33%47.74K-23.78%684.53K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg